Cargando…

Procedural Intervention for Benign Prostatic Hyperplasia in Men ≥ Age 70 Years – A Review of Published Literature

OBJECTIVE: We set out to review studies reporting on the use of surgical intervention to treat Benign Prostatic Hyperplasia in elderly men ≥70 years of age. METHODS: A systematic literature search was conducted using Scopus, PubMed-MEDLINE, Cochrane, and Wiley Online Library databases including stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Codelia-Anjum, Alia J, Berjaoui, Mohamad Baker, Khondker, Adree, Elterman, Dean, Zorn, Kevin C, Bhojani, Naeem, Lerner, Lori B, Chughtai, Bilal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577238/ https://www.ncbi.nlm.nih.gov/pubmed/37849957 http://dx.doi.org/10.2147/CIA.S414799

Ejemplares similares

Enterococcal Urinary Tract Infections: A Review of the Pathogenicity, Epidemiology, and Treatment
por: Codelia-Anjum, Alia, et al.
Publicado: (2023)

Patients' Perspectives on Attributes While Choosing Minimally Invasive Surgery for Benign Prostatic Hyperplasia Procedures: Experience from Men Undergoing Water Vapor Thermal Therapy
por: Rojanasarot, Sirikan, et al.
Publicado: (2023)

Recent advances in managing benign prostatic hyperplasia: The Rezūm System
por: Guelce, Dominique, et al.
Publicado: (2018)

A Community-Based Education Program for Overactive Bladder in a Predominantly Minority Older Female Population: A Pilot Study
por: Martinez Díaz, Susana, et al.
Publicado: (2022)

Putting Patients Ahead by Leaving Nothing Behind: An Emerging Treatment Paradigm in Minimally Invasive Surgical Therapy for Benign Prostatic Hyperplasia
por: McVary, Kevin T, et al.
Publicado: (2021)

Transfusion rates after 800 Aquablation procedures using various haemostasis methods
por: Elterman, Dean, et al.
Publicado: (2020)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Commentary on “Solving the benign prostatic hyperplasia puzzle”
por: Thomas, Dominique, et al.
Publicado: (2018)

WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30–80-cm(3) and 80–150-cm(3) Prostates
por: Nguyen, David-Dan, et al.
Publicado: (2021)

Alpha–blocker and apoptosis
por: Elterman, Dean S., et al.
Publicado: (2013)

Does urodynamics predict voiding after benign prostatic hyperplasia surgery in patients with detrusor underactivity?
por: Thomas, Dominique, et al.
Publicado: (2019)

The role of photovaporization of the prostate in small volume benign prostatic hyperplasia and review of the literature
por: Thomas, Dominique, et al.
Publicado: (2019)

Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30–80 and 80–150 mL prostates
por: Nguyen, David‐Dan, et al.
Publicado: (2019)

Contemporary review of the 532 nm laser for treatment of benign prostatic hyperplasia
por: Chughtai, Bilal, et al.
Publicado: (2015)

Aquablation therapy in large prostates (80–150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3‐year trial results
por: Zorn, Kevin C., et al.
Publicado: (2021)

An Evaluation of Sexual Function in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia in Men Treated with the Temporarily Implanted Nitinol Device
por: Elterman, Dean, et al.
Publicado: (2022)

How do bacterial membranes resist polymyxin antibiotics?
por: Khondker, Adree, et al.
Publicado: (2020)

Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia
por: Chughtai, Bilal, et al.
Publicado: (2021)

Meta-analysis with individual data of functional outcomes following Aquablation for lower urinary tract symptoms due to BPH in various prostate anatomies
por: Elterman, Dean, et al.
Publicado: (2021)

Membrane-Accelerated Amyloid-β Aggregation and Formation of Cross-β Sheets
por: Khondker, Adree, et al.
Publicado: (2017)

Conformational plasticity of the HIV-1 gp41 immunodominant region is recognized by multiple non-neutralizing antibodies
por: Cook, Jonathan D., et al.
Publicado: (2022)

The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)
por: Woo, Henry H., et al.
Publicado: (2022)

A Standardized Method for Estimating the Carbon Footprint of Disposable Minimally Invasive Surgical Devices: Application in Transurethral Prostate Surgery
por: Misrai, Vincent, et al.
Publicado: (2021)

Glucose Can Protect Membranes against Dehydration Damage by Inducing a Glassy Membrane State at Low Hydrations
por: Dhaliwal, Alexander, et al.
Publicado: (2019)

Water vapor thermal therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: Systematic review and meta-analysis
por: Miller, Larry E., et al.
Publicado: (2020)

The Lipid Bilayer Provides a Site for Cortisone Crystallization at High Cortisone Concentrations
por: Alsop, Richard J., et al.
Publicado: (2016)

Educational exposures associated with preclinical medical student interest in pursuing surgical residency: Longitudinal mixed-methods study with narrative evaluation
por: Khondker, Adree, et al.
Publicado: (2023)

A comprehensive analysis of clinical, quality of life, and cost-effectiveness outcomes of key treatment options for benign prostatic hyperplasia
por: Chughtai, Bilal, et al.
Publicado: (2022)

Benign Prostatic Hyperplasia
Publicado: (2015)

Bipolar transurethral enucleation of prostate versus photoselective vaporization for symptomatic benign prostatic hyperplasia (>70 ml)
por: Mu, Xiao-Nan, et al.
Publicado: (2017)

Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes
por: Liu, Deli, et al.
Publicado: (2020)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Benchtop-fabricated lipid-based electrochemical sensing platform for the detection of membrane disrupting agents
por: Saem, Sokunthearath, et al.
Publicado: (2020)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_72ebium33com1hpkoucnf7hotr